4/29/2022CDE Seeks Participation for Questionnaire Survey on Pediatric Drug R&D...

4/29/2022BMS and Chinese Partner LianBio Won FDA Nod for Camzyos to Treat Hea...

4/29/2022NHSA and NHC Issue Notice to Improve National 6th VBP (Insulin Program...

4/29/2022Recent Executive Moves

4/29/2022Drug R&D and Product Registration News Digest April 2022 (4)

4/29/2022Financial-related Company News Digest

4/29/2022Adagene-Sanofi's $2.5B Deal Tops March Deals in China (PharmaDJ)

4/28/2022The Three Key Drivers That Are Shaping China's Cell and Gene Therapy I...

4/28/2022Biotech Venture Capital Investment in China Climbs (WSJ)

4/28/2022NMPA Holds Meeting to Review Vaccine Regulatory Quality Management Sys...

4/28/2022Stevanato Group Acquires Manufacturing Facility in Zhejiang to Suppor...

4/28/2022Sales Expenditures of Listed Chinese Pharma Companies Sharply Up Again...

4/28/2022SMEI Revises Down Chinese Pharma Industry Growth Projection in 2022

4/28/2022Sanofi Reports Q1/2022 Performance, Witnessing 13.4% Growth in China

4/27/2022Xbiome Acquires Clinical-Stage Program Targeting Ulcerative Colitis

4/27/2022Lupin Inks Pact with Yabao to Market Pediatric Formulations in China

4/27/2022China Biotech CEO Podcast: CANbridge's Xue On Orphan Drug Coverage, Fi...

4/27/2022More Than Half of IBD Patients in China Have Poor Response to Anti-TNF...

4/27/2022Significant Increase in Diabetes Prevalence Observed in China

4/26/2022China Clears Homegrown PD-1 Inhibitors for Solid Tumors (PharmaDJ's Ch...

4/26/2022Arrowhead and Vivo Capital Launch JV Aimed at Greater China Market

4/26/2022AstraZeneca Remain Bullish on Long-term Development in China

4/26/2022NMPA and Chinese Customs Announce Addition of Zhongshan City's Zhongsh...

4/26/2022CDE Publicizes the List of Reference Formulations for GQCE Studies (58...

4/26/2022AstraZeneca Plans Innovation Center for Traditional Chinese Medicines

4/25/2022Porton and Sinorda Enter Strategic Collaboration to Accelerate Cell Th...

4/25/2022AstraZeneca Withdraws Suits After SPC Sidesteps Review of "Reverse Pay...

4/25/2022Review of Chinese Biopharma IPOs in 2021

4/25/2022NMPA Announces Package Insert Revision of Hoclocarpine Hydrobromide In...

4/25/2022CDE Issues the List of Reference Formulations for GQCE Studies (53rd B...

Page:86/719 Total number of articles:21546: [First][<<] [84] [85] [86] [87] [88] [>>] [End]